Literature DB >> 18334921

Changes in consensus arylamine N-acetyltransferase gene nomenclature.

David W Hein1, Sotiria Boukouvala, Denis M Grant, Rodney F Minchin, Edith Sim.   

Abstract

Changes in consensus arylamine N-acetyltransferase (NAT) gene nomenclature determined at the 2007 International NAT Workshop include: (1) Alleles in all species except mouse and rat are all uppercase. For mouse and rat, the first letter is upper case followed by lower case. (2) The nomenclature system is now species-specific. Thus, NAT2(*)1 (chicken), NAT2(*)2 and NAT2(*)3 (rabbit), Nat2(*)8 Nat2(*)9, Nat2(*)22 and Nat2(*)23 (mouse), NAT2(*)15, NAT2(*)16A and NAT2(*)16B (Syrian hamster), and NAT2(*)20, NAT2(*)21A and NAT2(*)21B (rat) are retired and renumbered within a species. A species modifier incorporated into the allele designation is written in upper case Roman font, e.g., (MOUSE)Nat1(*)1 is now the reference Nat1 allele in mouse; and (3) The NAT website also can now be accessed at a webalias address: http://N-acetyltransferasenomenclature.louisville.edu. New NAT alleles should continue to be submitted to the NAT Nomenclature Committee for inclusion on the website to ensure proper categorization and to continue consistency in nomenclature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334921      PMCID: PMC2386960          DOI: 10.1097/FPC.0b013e3282f60db0

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  2 in total

1.  Update on consensus arylamine N-acetyltransferase gene nomenclature.

Authors:  D W Hein; D M Grant; E Sim
Journal:  Pharmacogenetics       Date:  2000-06

Review 2.  Nomenclature for N-acetyltransferases.

Authors:  K P Vatsis; W W Weber; D A Bell; J M Dupret; D A Evans; D M Grant; D W Hein; H J Lin; U A Meyer; M V Relling
Journal:  Pharmacogenetics       Date:  1995-02
  2 in total
  25 in total

Review 1.  Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

Authors:  L V Kalman; Jag Agúndez; M Lindqvist Appell; J L Black; G C Bell; S Boukouvala; C Bruckner; E Bruford; K Caudle; S A Coulthard; A K Daly; Al Del Tredici; J T den Dunnen; K Drozda; R E Everts; D Flockhart; R R Freimuth; A Gaedigk; H Hachad; T Hartshorne; M Ingelman-Sundberg; T E Klein; V M Lauschke; D R Maglott; H L McLeod; G A McMillin; U A Meyer; D J Müller; D A Nickerson; W S Oetting; M Pacanowski; V M Pratt; M V Relling; A Roberts; W S Rubinstein; K Sangkuhl; M Schwab; S A Scott; S C Sim; R K Thirumaran; L H Toji; R F Tyndale; Rhn van Schaik; M Whirl-Carrillo; Ktj Yeo; U M Zanger
Journal:  Clin Pharmacol Ther       Date:  2015-11-20       Impact factor: 6.875

Review 2.  Pharmacogenetics in Jewish populations.

Authors:  Yao Yang; Inga Peter; Stuart A Scott
Journal:  Drug Metabol Drug Interact       Date:  2014

Review 3.  Clinically relevant genetic variations in drug metabolizing enzymes.

Authors:  Navin Pinto; M Eileen Dolan
Journal:  Curr Drug Metab       Date:  2011-06       Impact factor: 3.731

4.  Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland.

Authors:  LaCreis R Kidd; David W Hein; Karen Woodson; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Joseph A Tangrea
Journal:  Biochem Genet       Date:  2010-10-08       Impact factor: 1.890

Review 5.  Databases in the area of pharmacogenetics.

Authors:  Sarah C Sim; Russ B Altman; Magnus Ingelman-Sundberg
Journal:  Hum Mutat       Date:  2011-04-05       Impact factor: 4.878

6.  Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations.

Authors:  Holly M Mortensen; Alain Froment; Godfrey Lema; Jean-Marie Bodo; Muntaser Ibrahim; Thomas B Nyambo; Sabah A Omar; Sarah A Tishkoff
Journal:  Pharmacogenomics       Date:  2011-10-13       Impact factor: 2.533

Review 7.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

Review 8.  N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.

Authors:  David W Hein
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-04       Impact factor: 4.481

Review 9.  PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Authors:  Ellen M McDonagh; Sotiria Boukouvala; Eleni Aklillu; David W Hein; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-08       Impact factor: 2.089

10.  The actinobacterium Tsukamurella paurometabola has a functionally divergent arylamine N-acetyltransferase (NAT) homolog.

Authors:  Vasiliki Garefalaki; Evanthia Kontomina; Charalambos Ioannidis; Olga Savvidou; Christina Vagena-Pantoula; Maria-Giusy Papavergi; Ioannis Olbasalis; Dionysios Patriarcheas; Konstantina C Fylaktakidou; Tamás Felföldi; Károly Márialigeti; Giannoulis Fakis; Sotiria Boukouvala
Journal:  World J Microbiol Biotechnol       Date:  2019-10-31       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.